The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
If it’s a dcf valuation it will be the value of the investment as at today, based on the assumptions used in the model. At the moment it looks like the market has a different set of assumptions….likely the probability of success.
Do ADRs work if the shares aren’t on another exchange? I though the ADRs worked because US bankers can buy the underlying shares on an exchange? If Accustem isn’t on LSE then how would ADRs work?
It was there because it was in the January presentation which is still on the website. Have they licensed p2 out?
Looks like the Accustem change from ltd to plc is done as per resolutions at co hse. Must have been voted on when part of planwise subject to the demerger agreement which means new shareholders don’t need to vote a special res. That should just now mean the 10 days notice of intention to list is needed.
Not ‘no ok’ but ‘book’
The valuation would be based on a discounted cash flow or dividend discount basis....but seeing as there is no trading history it’s likely to be based on similar market transactions. Are there any? The company will engage someone to value but no ok value probably doesn’t reflect market value on that basis... the cost of building something is often lower than it’s worth.
However I can’t see it just being a listing, the company will need funds to deliver its plan and therefore an ipo may be needed, in which case it could be restricted and the value will be set as they build the book with institutional investors.
@dumbldoresbeard yes that’s right they have to allot the shares to shareholders whether they float or not. The divi in specie was at book value (as normal for these things) of c. £3.07m per the RNS. The allotment at 1.58p gets to £3.22m.. so looks right. What the valuation is on ipo or sale is the exciting bit!
Looks like they are catching up in the simple governance that they were so far behind on. The PSC for stemprinter has been updated to Accustem as well. Each time a company allots shares it has to complete an allotment form .. there is no link to any buyer or other reason for that.. they ha e to state that it was for Stemprinter transfer as they didn’t actually receive cash. Good to see they are completing this stuff now though. Hopefully means they are getting their ducks in a row?
I welcome GC being on board. The fact that it has taken 5m to record something that has to be done in 14 days is the irk. Those forms take about 34 seconds to complete online!
Hi
RTO would make sense and explain delay, with a main market shell (from memory) needing a delisting/relisting or re-admission of enlarged new group. Target shell would have to be announcing something soon (fingers crossed).
I will continue to hold btw
Hi. Tiziana don’t, I agree....but doesn’t Accustem? It’s not listed at the moment and can’t list without being a plc can it, which needs a special res?
Hi. Holder for over 12m now.
I emailed Willy Simon at the company regarding the PSC register at companies house. There haven’t been any updates in the required timeframe under CA2006. Tiziana is still showing for Accustem and Stemprinter which isn’t correct. I haven’t had a response. They do need to respond within 5 business days for a formal request, which mine wasn’t.
Also, for the Q1 deadline to be met the exchange needs to be notified within 10 working days of 31st Mar. That’s the 17th. We need a special res to change Accustem to a plc from a limited company. That’s 14 days for a gm as well. Which means we need to get a notice of meeting tomorrow, 3rd, to hit?
Thanks to everyone’s comms on this board.